 3. Participants who received an immunosuppressive agent or other immunomodulator agent for a long term for 14 days or more within 6 months of the first vaccination, or systematic corticosteroid however, a topical corticosteroid is allowed, such as ointment, eye drops, inhalant, or nasal spray; 